The IBMS issues a response to The Independent’s news story “Failing the test: Slow start and flawed decisions in Britain’s coronavirus testing have cost lives, warn health leaders”.
As we await the government’s announcement on its 100,000 ‘test’ target, the IBMS members and laboratory staff are working tirelessly to prepare for the next phase of the coronavirus pandemic
With the emergence of mass testing centres, it must be restated that it is a global supply shortage holding NHS biomedical scientists back, not a lack of capacity
The IBMS, in collaboration with professional bodies RCPath, ACP and ACB, have issued joint guidance on the prioritisation of pathology testing during the COVID-19 pandemic
IBMS Chief Executive Jill Rodney has written a letter of support for our members seeking education provision for their children during the COVID-19 pandemic
The IBMS issues specification for biomedical scientists who could be deployed to support the diagnostic virology laboratory service during the SARS-2/COVID-19 pandemic
